Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2017

Open Access 01-12-2017 | Research article

Will the European Union reach the United Nations Millennium declaration target of a 50% reduction of tuberculosis mortality between 1990 and 2015?

Authors: Marieke J. van der Werf, Sandro Bonfigli, Frantiska Hruba

Published in: BMC Public Health | Issue 1/2017

Login to get access

Abstract

Background

The Millennium Development Goals (MDG) provide targets for 2015. MDG 6 includes a target to reduce the tuberculosis (TB) death rate by 50% compared with 1990. We aimed to assess whether this target was reached by the European Union (EU) and European Economic Area countries.

Methods

We used Eurostat causes of death data to assess whether the target was reached in the EU. We calculated the reduction in reported and adjusted death rates and the annual average percentage decline based on the available data.

Results

Between 1999 and 2014, the TB death rate decreased by 50%, the adjusted death rate by 56% and the annual average percentage decline was 5.43% (95% confidence interval 4.94–6.74) for the EU. Twenty of 26 countries reporting >5 TB deaths in the first reporting year reached the target of 50% reduction in adjusted death rate.

Conclusions

The EU reached the MDG target of a 50% reduction of the TB death rate and also the annual average percentage decline was larger than the 2.73% needed to reach the target. The World Health Organization ‘End TB Strategy’ requires a further reduction of the number of TB deaths of 35% by 2020 compared to 2015, which will challenge TB prevention and care services in the EU.
Literature
1.
2.
3.
World Health Assymbly. Resolution WHA. 44.8. In: Forty-fourth world health assembly, Geneva, 6–16 may, 1991. Resolutions and decisions. Geneva: World Health Organization;1991 (WHA44/1991/REC/1); 1991.
4.
Stop TB Partnership. The global plan to stop TB, 2006–2015. Geneva: World Health Organization. p. 2006.
5.
World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization; 2015.
6.
Antoine D, Schwoebel V, Veen J, Raviglione MC, Rieder HL. Surveillance of tuberculosis in the WHO European Region 1995-1996. Euro Surveill. 1998 Nov;3(11):103–7.PubMed
7.
European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe, 2016. Stockholm: European Centre for Disease prevention and Control (ECDC); 2016.
8.
Glaziou P, van der Werf MJ, Onozaki I, Dye C, Borgdorff MW, Chiang CY, et al. Tuberculosis prevalence surveys: rationale and cost. Int J Tuberc Lung Dis. 2008 Sep;12(9):1003–8.PubMed
9.
10.
World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization; 2014.
11.
Jung RS, Bennion JR, Sorvillo F, Bellomy A. Trends in tuberculosis mortality in the United States, 1990-2006: a population-based case-control study. Public Health Rep. 2010 May-Jun;125(3):389–97.CrossRefPubMedPubMedCentral
12.
Gonzalez E, Risco GE, Borroto S, Perna A, Armas L. Tuberculosis mortality trends in cuba, 1998 to 2007. MEDICC Rev. 2009 Jan;11(1):42–7.PubMed
13.
Hino P, da Costa-Junior ML, Sassaki CM, Oliveira MF, Villa TC, dos Santos CB. Time series of tuberculosis mortality in Brazil (1980-2001). Rev Lat Am Enfermagem. 2007 Sep-Oct;15(5):936–41.CrossRefPubMed
14.
15.
Lui G, Wong RY, Li F, Lee MK, Lai RW, Li TC, et al. High mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting. PLoS One. 2014;9(3):e92077.CrossRefPubMedPubMedCentral
16.
Greenaway C, Menzies D, Fanning A, Grewal R, Yuan L, FitzGerald JM, et al. Delay in diagnosis among hospitalized patients with active tuberculosis--predictors and outcomes. Am J Respir Crit Care Med. 2002 Apr 1;165(7):927–33.CrossRefPubMed
17.
Cruz-Ferro E, Ursua-Diaz MI, Taboada-Rodriguez JA, Hervada-Vidal X, Anibarro L, Tunez V, et al. Epidemiology of tuberculosis in Galicia, Spain, 16 years after the launch of the Galician tuberculosis programme. Int J Tuberc Lung Dis. 2014 Feb;18(2):134–40.CrossRefPubMed
18.
Saldana L, Abid M, McCarthy N, Hunter N, Inglis R, Anders K. Factors affecting delay in initiation of treatment of tuberculosis in the Thames Valley, UK. Public Health. 2013 Feb;127(2):171–7.CrossRefPubMed
19.
Jurcev Savicevic A, Popovic-Grle S, Milovac S, Ivcevic I, Vukasovic M, Viali V, et al. Tuberculosis knowledge among patients in out-patient settings in split, Croatia. Int J Tuberc Lung Dis. 2008 Jul;12(7):780–5.PubMed
20.
DeRiemer K, Rudoy I, Schecter GF, Hopewell PC, Daley CL. The epidemiology of tuberculosis diagnosed after death in San Francisco, 1986-1995. Int J Tuberc Lung Dis. 1999 Jun;3(6):488–93.PubMed
21.
Rieder HL, Kelly GD, Bloch AB, Cauthen GM, Snider DE Jr. Tuberculosis diagnosed at death in the United States. Chest. 1991 Sep;100(3):678–81.CrossRefPubMed
22.
Wu YC, Lo HY, Yang SL, Chou P. Factors correlated with tuberculosis reported after death. Int J Tuberc Lung Dis. 2014 Dec;18(12):1485–90.CrossRefPubMed
23.
van der Werf MJ, Langendam MW, Huitric E, Manissero D. Knowledge of tuberculosis-treatment prescription of health workers: a systematic review. Eur Respir J. 2012 May;39(5):1248–55.CrossRefPubMed
24.
Walpola HC, Siskind V, Patel AM, Konstantinos A, Derhy P. Tuberculosis-related deaths in Queensland, Australia, 1989-1998: characteristics and risk factors. Int J Tuberc Lung Dis. 2003 Aug;7(8):742–50.PubMed
25.
Takahara M. Clinical evaluation of causes of death in patients with pulmonary tuberculosis. Kekkaku. 2004 Dec;79(12):711–6.PubMed
26.
European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe, 2017. Stockholm: European Centre for Disease prevention and Control (ECDC); 2017.
27.
Miller TL, Wilson FA, Pang JW, Beavers S, Hoger S, Sharnprapai S, et al. Mortality hazard and survival after tuberculosis treatment. Am J Public Health. 2015 May;105(5):930–7.CrossRefPubMedPubMedCentral
28.
Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, et al. Pulmonary impairment after tuberculosis. Chest. 2007 Jun;131(6):1817–24.CrossRefPubMed
29.
Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000 Jan;55(1):32–8.CrossRefPubMedPubMedCentral
30.
Pablos-Mendez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA. 1996 Oct 16;276(15):1223–8.CrossRefPubMed
31.
Kayigamba FR, Bakker MI, Mugisha V, De Naeyer L, Gasana M, Cobelens F, et al. Adherence to tuberculosis treatment, sputum smear conversion and mortality: a retrospective cohort study in 48 Rwandan clinics. PLoS One. 2013;8(9):e73501.CrossRefPubMedPubMedCentral
32.
Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005 Mar;83(3):171–7.PubMedPubMedCentral
33.
Phillips DE, Lozano R, Naghavi M, Atkinson C, Gonzalez-Medina D, Mikkelsen L, et al. A composite metric for assessing data on mortality and causes of death: the vital statistics performance index. Popul Health Metr. 2014;12:14.CrossRefPubMedPubMedCentral
34.
World Health Organization Sixty-Seventh World Health Assembly. A67/11. Global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization; 2014.
35.
Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO’s new end TB strategy. Lancet. 2015 May 2;385(9979):1799–801.CrossRefPubMed
36.
Lonnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J. 2015 Apr;45(4):928–52.PubMedPubMedCentral
37.
Metadata
Title
Will the European Union reach the United Nations Millennium declaration target of a 50% reduction of tuberculosis mortality between 1990 and 2015?
Authors
Marieke J. van der Werf
Sandro Bonfigli
Frantiska Hruba
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2017
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-017-4544-9

Other articles of this Issue 1/2017

BMC Public Health 1/2017 Go to the issue

Research article

Adolescent reserve capacity, socioeconomic status and school achievement as predictors of mortality in Finland - a longitudinal study

Research article

Double Up Food Bucks program effects on SNAP recipients' fruit and vegetable purchases

Research article

Pesticide poisoning in Chitwan, Nepal: a descriptive epidemiological study

Research article

Challenges of implementing the integrated disease surveillance and response strategy in Zambia: a health worker perspective

Study protocol

The Norwegian Healthy Life Study: protocol for a pragmatic RCT with longitudinal follow-up on physical activity and diet for adults

Research article

Building social capital to promote adolescent wellbeing: a qualitative study with teens in a Latino agricultural community